Insider · CIK 0001955244
David M Berman
Files at IMCR (Immunocore Holdings plc). First filing Feb 28, 2024, latest Feb 19, 2026.
In brief
David M Berman files SEC Form 4 as officer at IMCR (Immunocore Holdings plc). Since Feb 28, 2024, David M Berman has reported 0 open-market buys worth $0 and 9 open-market sells worth $18M, the latest filed on Feb 19, 2026.
A track record needs three past buys with six months of prices behind them; David M Berman has 0, so none is measured yet.
The newest scored trade: sold $193k of IMCR on Feb 18, 2026, filed Feb 19, 2026, scored 47 (moderate). In the last 12 months: 0 buys worth $0 and 4 sells worth $5.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMCR: Immunocore Holdings plc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Immunocore Holdings plc | $193k 5,965 shares | -50% | +33% from low-19% from high | |
| 25Weak | Immunocore Holdings plc | $1.3M 31,913 shares | -102% | +64% from low0% from high | |
| 25Weak | Immunocore Holdings plc | $3.0M 74,925 shares | -108% | +64% from low0% from high | |
| 21Weak | Immunocore Holdings plc | $725k 18,120 shares | -18120% | +58% from low-2% from high | |
| 25Weak | Immunocore Holdings plc | $2.2M 61,849 shares | -100% | +48% from low-6% from high | |
| 22Weak | Immunocore Holdings plc | $811k 22,732 shares | -101% | +44% from low-9% from high | |
| 25Weak | Immunocore Holdings plc | $1.8M 50,419 shares | -161% | +48% from low-6% from high | |
| 25Weak | Immunocore Holdings plc | $2.5M 36,509 shares | -100% | +62% from low-8% from high | |
| 25Weak | Immunocore Holdings plc | $5.9M 83,491 shares | -292% | +66% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 22, 2026 | IMCR Immunocore Holdings PLC | 69,271 0.14% of outstanding | $2.0M | May 22, 2026 | $3.1M |
| May 21, 2026 | IMCR Immunocore Holdings PLC | 65,000 0.13% of outstanding | $1.9M | May 21, 2026 | $1.2M |
| Apr 8, 2026 | IMCR Immunocure Holdings PLC | 25,000 0.05% of outstanding | $796k | Apr 8, 2026 | $578k |
| Mar 11, 2026 | IMCR Immunocure Holdings PLC | 11,832 0.02% of outstanding | $385k | Mar 11, 2026 | $193k |
| Feb 18, 2026 | IMCR Immunocore Holdings PLC | 5,965 0.01% of outstanding | $193k | Feb 18, 2026 | $5.0M |
| Nov 24, 2025 | IMCR Immunocore Holdings plc | 136,790 0.27% of outstanding | $5.4M | Nov 24, 2025 | $4.8M |
| Sep 10, 2025 | IMCR Immunocore Holdings plc | 135,000 0.27% of outstanding | $4.9M | Sep 10, 2025 | none |
| Feb 26, 2024 | IMCR Immunocore Holdings Plc | 120,000 0.24% of outstanding | $8.5M | Feb 26, 2024 | $6.2M |
| Nov 30, 2023 | IMCR Immunocore Holdings Plc | 120,000 0.25% of outstanding | $6.2M | Nov 30, 2023 | none |
| Nov 16, 2023 | IMCR Immunocore Holdings PLC | 7,550 0.02% of outstanding | $357k | Nov 16, 2023 | $2.1M |
| Nov 6, 2023 | IMCR Immunocore Holdings PLC | 25,430 0.05% of outstanding | $1.2M | Nov 6, 2023 | $916k |
Transactions
The newest 50 of 57 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares | +11,824 | $0.00 | $0 | 11,824 | Feb 19, 2026 |
| Feb 18, 2026 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares | -5,965 | $32.35 | $193k | 5,859 | Feb 19, 2026 |
| Feb 17, 2026 | IMCR Immunocore Holdings plc | MOption exercise Restricted Share Unitsderivative | -11,824 | $0.00 | $0 | 35,473 | Feb 19, 2026 |
| Dec 4, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +31,341 | $17.46 | $547k | 31,341 | Dec 8, 2025 |
| Dec 4, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -31,341 | $40.26 | $1.3M | 0 | Dec 8, 2025 |
| Dec 5, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +572 | $17.46 | $9,987 | 572 | Dec 8, 2025 |
| Dec 5, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -572 | $40.14 | $23k | 0 | Dec 8, 2025 |
| Dec 4, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -31,341 | $0.00 | $0 | 12,404 | Dec 8, 2025 |
| Dec 5, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -572 | $0.00 | $0 | 11,832 | Dec 8, 2025 |
| Nov 26, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +69,404 | $17.46 | $1.2M | 69,404 | Dec 1, 2025 |
| Nov 26, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -69,404 | $40.12 | $2.8M | 0 | Dec 1, 2025 |
| Nov 28, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +5,521 | $17.46 | $96k | 5,521 | Dec 1, 2025 |
| Nov 28, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -5,521 | $40.09 | $221k | 0 | Dec 1, 2025 |
| Nov 26, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -69,404 | $0.00 | $0 | 49,266 | Dec 1, 2025 |
| Nov 28, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -5,521 | $0.00 | $0 | 43,745 | Dec 1, 2025 |
| Nov 24, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +100 | $17.46 | $1,746 | 100 | Nov 26, 2025 |
| Nov 24, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -100 | $40.00 | $4,000 | 0 | Nov 26, 2025 |
| Nov 25, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +18,020 | $17.46 | $315k | 18,020 | Nov 26, 2025 |
| Nov 25, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -18,020 | $40.03 | $721k | 0 | Nov 26, 2025 |
| Nov 24, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -100 | $0.00 | $0 | 136,690 | Nov 26, 2025 |
| Nov 25, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -18,020 | $0.00 | $0 | 118,670 | Nov 26, 2025 |
| Sep 30, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +61,849 | $17.46 | $1.1M | 61,849 | Oct 2, 2025 |
| Sep 30, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -61,849 | $35.23 | $2.2M | 0 | Oct 2, 2025 |
| Sep 30, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -61,849 | $0.00 | $0 | 136,790 | Oct 2, 2025 |
| Sep 12, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +22,532 | $17.46 | $393k | 22,532 | Sep 16, 2025 |
| Sep 12, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -21,232 | $35.63 | $756k | 1,300 | Sep 16, 2025 |
| Sep 12, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -1,300 | $36.31 | $47k | 0 | Sep 16, 2025 |
| Sep 15, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +200 | $17.46 | $3,492 | 200 | Sep 16, 2025 |
| Sep 15, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -200 | $35.01 | $7,002 | 0 | Sep 16, 2025 |
| Sep 12, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -22,532 | $0.00 | $0 | 198,839 | Sep 16, 2025 |
| Sep 15, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -200 | $0.00 | $0 | 198,639 | Sep 16, 2025 |
| Sep 10, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +31,338 | $17.46 | $547k | 31,338 | Sep 12, 2025 |
| Sep 10, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -30,138 | $36.12 | $1.1M | 1,200 | Sep 12, 2025 |
| Sep 10, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -1,200 | $36.77 | $44k | 0 | Sep 12, 2025 |
| Sep 11, 2025 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +19,081 | $17.46 | $333k | 19,081 | Sep 12, 2025 |
| Sep 11, 2025 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -19,081 | $36.28 | $692k | 0 | Sep 12, 2025 |
| Sep 10, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -31,338 | $0.00 | $0 | 240,452 | Sep 12, 2025 |
| Sep 11, 2025 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -19,081 | $0.00 | $0 | 221,371 | Sep 12, 2025 |
| Feb 17, 2025 | IMCR Immunocore Holdings plc | AGrant or award Employee Share Option (Right to Buy)derivative | +129,518 | $0.00 | $0 | 129,518 | Feb 19, 2025 |
| Feb 17, 2025 | IMCR Immunocore Holdings plc | AGrant or award Restricted Share Unitsderivative | +47,297 | $0.00 | $0 | 47,297 | Feb 19, 2025 |
| Feb 28, 2024 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +36,509 | $17.46 | $637k | 36,509 | Mar 1, 2024 |
| Feb 28, 2024 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -16,900 | $67.61 | $1.1M | 19,609 | Mar 1, 2024 |
| Feb 28, 2024 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -7,472 | $68.84 | $514k | 12,137 | Mar 1, 2024 |
| Feb 28, 2024 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -10,937 | $69.73 | $763k | 1,200 | Mar 1, 2024 |
| Feb 28, 2024 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -1,200 | $70.45 | $85k | 0 | Mar 1, 2024 |
| Feb 28, 2024 | IMCR Immunocore Holdings plc | MOption exercise Employee Share Option (Right to Buy)derivative10b5-1 | -36,509 | $0.00 | $0 | 271,790 | Mar 1, 2024 |
| Feb 26, 2024 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +28,553 | $17.46 | $499k | 28,553 | Feb 28, 2024 |
| Feb 26, 2024 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -26,516 | $70.60 | $1.9M | 2,037 | Feb 28, 2024 |
| Feb 26, 2024 | IMCR Immunocore Holdings plc | SOpen-market sale Ordinary Shares10b5-1 | -2,037 | $71.31 | $145k | 0 | Feb 28, 2024 |
| Feb 27, 2024 | IMCR Immunocore Holdings plc | MOption exercise Ordinary Shares10b5-1 | +54,938 | $17.46 | $959k | 54,938 | Feb 28, 2024 |
Questions about David M Berman
Answered from the filings on this page, as of the latest one.
Is David M Berman buying or selling?
In the last 12 months David M Berman reported 0 open-market buys worth $0 and 4 open-market sells worth $5.2M on SEC Form 4; the latest was sold $193k of IMCR on Feb 18, 2026. Grants, option exercises and tax withholding are not counted.
How did David M Berman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David M Berman has 0.
Where does David M Berman file Form 4?
David M Berman has filed Form 4 at IMCR (Immunocore Holdings plc) as HEAD OF R&D. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.